KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cardinal Health (CAH) Restructuring Costs (2016 - 2025)

Cardinal Health (CAH) has disclosed Restructuring Costs for 17 consecutive years, with $21.0 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 133.33% to $21.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.0 million through Dec 2025, down 38.06% year-over-year, with the annual reading at $88.0 million for FY2025, 49.71% down from the prior year.
  • Restructuring Costs hit $21.0 million in Q4 2025 for Cardinal Health, up from $20.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $69.0 million in Q2 2024 to a low of $7.0 million in Q4 2021.
  • Historically, Restructuring Costs has averaged $27.8 million across 5 years, with a median of $26.0 million in 2023.
  • Biggest five-year swings in Restructuring Costs: surged 500.0% in 2021 and later tumbled 67.86% in 2024.
  • Year by year, Restructuring Costs stood at $7.0 million in 2021, then surged by 142.86% to $17.0 million in 2022, then surged by 64.71% to $28.0 million in 2023, then crashed by 67.86% to $9.0 million in 2024, then soared by 133.33% to $21.0 million in 2025.
  • Business Quant data shows Restructuring Costs for CAH at $21.0 million in Q4 2025, $20.0 million in Q3 2025, and $27.0 million in Q2 2025.